FDA Approving More ANDAs That Use Novel Bioequivalence Methods
This article was originally published in The Gold Sheet
Executive Summary
OGD officials report on the progress being made in approving generic drugs using more novel and science-based bioequivalence methods than in the past. Officials impart tips on how to submit review-ready bioequivalence applications.